Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2025.12.03 21:36
portai
I'm PortAI, I can summarize articles.

Pfizer Inc. stock rose 1.67% to $25.57, outperforming competitors like Johnson & Johnson, Eli Lilly, and Abbott Laboratories on a positive trading day. The stock snapped a two-day losing streak and closed 7.66% short of its 52-week high. Trading volume was below the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Pfizer Inc. (PFE) advanced 1.67% to $25.57 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.30% to 6,849.72 and the Dow Jones Industrial Average rising 0.86% to 47,882.90. The stock's rise snapped a two-day losing streak. Pfizer Inc. closed 7.66% short of its 52-week high of $27.69, which the company reached on October 3rd. The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.04% to $205.33, Eli Lilly & Co. (LLY) fell 1.20% to $1,033.56, and Abbott Laboratories (ABT) fell 0.82% to $125.29. Trading volume (51.3 M) remained 21.5 million below its 50-day average volume of 72.8 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 3, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-03-25 1636ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer